Inhibitors of fatty acid cyclooxygenase (8,11,14-icosatrienoate, hydrogen dononoxygen oxidoreductase, EC 1.14.99.1) were found to suppress the establishment of the interferon-mediated antiviral state. The prevention, by these compounds, of the development of interferon protection correlated with the degree as well as the duration of cyclooxygenase inhibition. Anti-inflammatory substances lacking cyclooxygenase inhibitory activity did not interfere with the establishment of interferon protection. The addition of exogenous prosta-
glandins was not found to replace the need for a functional cyclooxygenase and, in some instances, could be shown to diminish the establishment of interferon protection. It is proposed that fatty acid cyclooxygenase is an essential component in the optimal induction of the interferon antiviral state. The application of interferon (IF) to cells results in the induction of an antiviral state which effectively suppresses the replication of both RNA and DNA viruses (1-3). Treatment with IF also induces or mediates various additional changes including alterations in cell surface properties, inhibition of mitosis, suppression of tumorigenesis, and modulation of cell-mediated immunity (4) (5) (6) (7) (8) (9) . The mechanism underlying many of these IF effects remains to be elucidated.
Establishment by IF of the antiviral state can be blocked by inhibitors of RNA and protein synthesis (10, 11) , indicating that establishment of the antiviral state by IF depends upon the expression of certain genetic information. Considerable attention has been directed to the IF-associated induction of new cellular enzymes such as protein kinase (12) (13) (14) (15) and 2,5-oligoadenylate synthetase (16) (17) (18) , although it is doubtful that induction of the latter enzyme is sufficient to explain the development of the antiviral state (19) . It has been postulated that IF-mediated membrane alterations may be important in the establishment of the antiviral condition (4) (5) (6) (7) .
We report here that in a murine system the enzyme fatty acid cyclooxygenase (8,11,14- icosatrienoate, hydrogen donor: oxygen oxidoreductase, EC 1.14.99.1) which is essential for the biosynthesis of prostaglandins (PGs) has an important role in the establishment of the IF-induced antiviral state.
MATERIALS AND METHODS Interferons. Partially purified IF from mouse C-243 cells with a specific activity of 2.0 X 107 reference units/mg of protein and control fluids (mock interferon) were prepared and kindly provided by Ion Gresser (Institut De Recherches Scientifiques Sur Le Cancer, Villejuif, France). Partially purified human lymphoblastoid IF with a specific activity of 0.58 X 106 reference units/mg of protein was derived and generously supplied by N. B. Finter (Wellcome Research Laboratories, Beckenham, England).
Cells and Medium. Mouse L cells (obtained from Samuel Baron, University of Texas, Galveston) were grown in minimal essential medium (GIBCO) supplemented with 4% fetal calf serum and antibiotics. Mouse 3T3C2 cells were grown in Dulbecco's modified minimal essential medium. Human foreskin fibroblast cells were grown in minimal essential medium containing 10% fetal calf serum. All of these cells were maintained in the respective media containing 2% fetal calf serum.
Virus. Vesicular stomatitis virus, originally provided by Ion Gresser, was prepared by passage in L cells and stored in small aliquots at -70°C. Virus titers were assessed in a plaque assay using a Methocel overlay medium. In every instance, mean titers were derived from 6 or 12 replicate wells; the titers and standard deviations were calculated and expressed as plaqueforming units (PFU)/ml. Chemicals. Acetylsalicylic acid, phenylbutazone, indomethacin, phenacetin, PGE1, and PGE2 were purchased from Sigma. Carbaprostacyclin (Upjohn compound U55185) and PG6 keto-Fla was from Upjohn. Oxyphenylbutazone was obtained from CIBA-Geigy, and naproxen from Syntex (Palo Alto, CA). Icosatetraynoic acid (ETYA) was a generous gift from W. E. Scott (Hoffman-La Roche, Nutley, NJ). PGH2 5-hydroperoxy-6,8,11,14-icosatetraenoic acid (5-HPETE), 5-hydroxy-6,8,11,14-icosatetraenoic acid (5-HETE), and 15-hydroperoxy-5,8,11,13-icosatetraenoic acid (15-HPETE) were kindly provided by N. Porter (Duke University) and ['4C]arachidonic acid (specific activity, 55 ,uCi/,umol, 1 Ci = 3.7 X 1010 becquerels) was obtained from Amersham.
Tests of the IF-Mediated Antiviral State. L-cell monolayers prepared in plastic plates containing 24 wells (1.5 cm2 per well) were treated with 100 international reference units of mouse IF per well or with mock IF diluted in minimal essential medium supplemented with 2% fetal calf serum. These cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2 in air. Various agents to be tested for their effect upon the IF-induced antiviral state were added simultaneously with the IF or 24 hr later, at the time of virus inoculation after the establishment of IF-mediated protection. After 24-hr incubation with IF or mock IF with and without the test additives, the monolayers were washed twice with fresh medium and inoculated with 0.1 ml of medium containing 105 PFU of vesicular stomatitis virus (average multiplicity of infection, 1.0). Additional (control) monolayers were inoculated with tissue culture medium alone. After adsorption (60 min at 37°C), the monolayers were washed twice with fresh cold medium, and 1 ml of minimal essential medium containing 2% fetal calf serum was added to each well. The cultures were incubated at 37°C in a The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
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Abbreviations: IF, interferon; PG, prostaglandin; PFU, plaque-forming units; 5-HPETE, 5-hydroperoxy-6,8,11,14-icosatetraenoic acid; 5-HETE, 5-hydroxy-6,8,11,14-icosatetraenoic acid; 15-HPTETE, 15- humidified atmosphere containing 5% CO2 in air. Supernatant fluids and cells from the different groups were harvested at various times up to 72 hr after virus inoculation and kept frozen until simultaneously assayed for virus titer.
The number and viability of the cells in the presence of all additives were monitored at each harvest point by the trypan blue exclusion technique. At the concentrations tested, there was no significant cellular toxicity detected in association with the addition of any of the PGs, cyclooxygenase inhibitors, or anti-inflammatory substances.
Role of PGs in the Establishment of the Antiviral State. To test the role of de novo PG biosynthesis in the establishment of the IF-mediated antiviral state, L cells were treated with 100 units of IF in the presence and absence of various inhibitors of cyclooxygenase: acetylsalicylic acid (1-100 MM), indomethacin (0.1-10 MM), oxyphenylbutazone (1-10 AM), phenylbutazone (1-10 MM), naproxen (1-100 MM), and ETYA (0.1-10 AM).
Additional substances used included the following nonsteroidal anti-inflammatory agents known to be devoid of cyclooxygenase inhibitory activity: phenacetin (0.1-10 AM) and sodium salicylate (1-100 AM). MM) also were used. The effect of these agents on the establishment of the IF-mediated anti-viral state was monitored as described above.
Assay for PG Biosynthesis. Possible specific alterations in PG biosynthesis in the presence of IF were monitored in mouse L cells, mouse 3T3C2, and human fibroblasts. Confluent cell monolayers were treated with homologous or heterologous IF (100-1000 reference units/ml) or corresponding dilutions of mock IF preparations for varying periods up to 24 hr. The monolayers were pulsed for 20 or 60 min with [1-14C]arachidonic acid (0.2 MCi/ml). Supernatant fluids and cells were processed separately and PGs were isolated, separated by thin-layer chromatography, visualized by autoradiography, and quantitated as described (20 100MAM) and phenacetin (100MM), potent anti-inflammatory drugs lacking cyclooxygenase inhibitory activity, did not suppress the IF-mediated antiviral effect. Aspirin, indomethacin, naproxen, ETYA, and phenylbutazone all decreased the extent of the antiviral protection afforded by IF, although the degree of reversal of the IF effect was considerably less than that achieved with oxyphenylbutazose. The extent of the reversal of IF protection varied from 10to 1000-fold, depending upon the cyclooxygenase inhibitor used and the time of virus harvest.
In the absence of IF the titer of virus reached a peak at 24 hr and diminished thereafter ( Fig. 1 ). Prior incubation of the cells with IF resulted in a sharp decline in virus production, although the time course of virus replication in IF-treated cells was similar to that in untreated monolayers; maximal titers were achieved at 24 hr and a decline was evident thereafter. In the presence of oxyphenylbutazone or PGE2 the protective effect of IF was diminished but not abolished. In this case, virus production was intermediate between that seen in untreated and in IF-treated cells, and titers continued to increase slowly during the entire 72-hr period of incubation.
In L cells previously incubated (24 hr) with IF, the addition of cyclooxygenase inhibitors did not reverse the antiviral state. In the absence of IF, the addition of some cyclooxygenase inhibitors to L cells resulted in a 2-fold increase in virus yield at 24 hr (Table 1) plates were treated with 100 ,um sodium salicylate, 10,uM oxyphenylbutazone, or 10 uM PGE2 with or without 100 reference units of mouse IF per ml for 24 hr. The monolayers were infected with 105 PFU of virus; after virus adsorption for 60 min, the monolayers were washed and the inoculum was replaced with minimal essential medium containing 2% fetal calf serum. The cells and supernatant fluids were harvested at various times thereafter and virus titers were determined in a plaque assay. At least six wells were pooled at each time point for each agent. The results are shown as mean I SD. These experiments were repeated three times at different multiplicities of virus infection (1.0,0.01, and 0.001) and yielded comparable results. 0-0, Control (no additives, no IF); -----0, IF alone; 0-0, sodium salicylate without IF; * *-, sodium salicylate with IF; ,-,, oxyphenylbutazone without IF; A ---A, oxyphenylbutazone with IF; X-X PGE2 without IF; I---X , PGE2 with IF.
Proc. Natl. Acad. Sci. USA 77 (1980) Proc. Natl. Acad. Sci. USA 77 (1980) 5439 2.1 + 0.65 X 103 L-cell monolayers in multiwell plates (1.5 cm2) were treated with the compounds listed (all at 10 ,uM except phenacetin was at 100M4M), with or without 100 international reference units of mouse interferon per mL Twelve replicate wells were maintained for each group. After 24 hr of incubation at 370C,9 of each set of 12 wells were infected with 105 PFU of vesicular stomatitis virus (multiplicity of infection, 1.0). The virus inoculum was replaced with minimal essential medium containing 2% fetal calf serum and further incubated. After 24 hr, all infected wells were simultaneously harvested by using three cycles of freezing and thawing. The products in the nine replicate wells that had been identically treated were pooled and the virus yield was determined in a plaque assay in L cells (12 wells per 1:10 dilution). Each compound was tested in this manner on at least four different occasions. The results in every case for each of the compounds were comparable. This table presents the results (mean i SD) of one set of these experiments. * PGH2 and PGI2 at a final concentration of 10MuM also suppressed the IF-associated antiviral state. However, these data are not included here because the experiments were performed separately and under different conditions.
Effect of Exogenous PGs on the IF-Mediated Antiviral
State in L Cells. Because PGs are the products of fatty acid cyclooxygenase, an attempt was made to overcome the reversal of IF protection by cyclooxygenase inhibitors by providing exogenous PGs. Addition of PGE1, PGE2, or 6-keto-PGFI. with cyclooxygenase inhibitors during IF pretreatment resulted in the further reversal of IF protection. In the absence of cyclooxygenase inhibitors, treatment with PGE1, PGE2, PGI2, or 6-keto-PGFI. (but not carbaprostacyclin) at doses of 1 gM or above resulted in inhibition of the IF-mediated protection (Table 1) , and addition of these agents to L cells after pretreatment with mouse IF for 24 hr did not result in the reversal of IF-associated protection.
Addition of arachidonic acid at 1-10,MM along with exogenous PGs and IF did not abrogate the reversal of IF protection. In addition, there was no detectable inhibition of cyclooxygenase function in the presence of exogenous PGs as monitored by the ability of the cell monolayers to convert exogenous [1-14C]arachidonic acid to PGs.
Addition of the lipooxygenase products 5-HPETE, 5-HETE, and 15-HPETE did not result in a significant reversal of the IF-mediated antiviral protection in L cells.
Effect of Nonsteroidal Anti-Inflammatory Substances or Exogenous PGs on Cyclooxygenase Activity. Oxyphenylbutazone, a compound that reversed IF protection substantially, also achieved the most effective and persistent reduction of cyclooxygenase activity in L cells ( Table 2) . Addition of oxyphenylbutazone at a concentration of 10 uM or more to the L-cell culture medium resulted in protracted (>14 hr) inhibition of cyclooxygenase activity as determined by the conversion L cells were grown to confluence. The monolayer was washed three times with phosphate-buffered saline, and then fresh medium containing 0.75% serum and each of the listed test compounds at 10 AM was added. Duplicate samples were pulsed with [1-"4C]arachidonic acid for 20 min, and the medium was analyzed for PGs (0-time samples). The remaining flasks were incubated for a further period of 14 hr and then pulsed with [1-14C]arachidonic acid for 20 min; and the medium was analyzed for PGs (14-hr samples). L cells synthesize two major arachidonic acid metabolites, as visualized by autoradiography, with Rf values of 0.32 and 0.46, respectively; the cpm given is the combined total of these two products. The mean + SD were derived from the results of eight separate comparable experiments. of [1-14C]arachidonic acid to PGs. Aspirin (10 MM), indomethacin (10MM), naproxen (100MgM), or phenylbutazone (10 MM) inhibited the enzyme for relatively shorter periods of time.
Unlike aspirin, inhibition of oxyphenylbutazone seems to require the continued presence of the inhibitor. When horse platelets were preincubated for 1 hr with oxyphenylbutazone, washed, resuspended, and pulsed with [1-14C]arachidonic acid, 65-75% of the enzyme activity could be detected by the appearance of hydroxyheptadecatrienoic acid among the reaction products. Nearly complete inhibition was observed when pulsing was done with the inhibitor present (data not given). The persistent inhibition of enzyme activity by this compound might thus reflect its resistance to metabolic degradation by the L cell monolayer.
Effect of IF on PG Synthesis. Because a previous report (5) described an increase in PG production during incubation with homologous IF, cells prelabeled with [1-'4C]arachidonic acid were incubated with IF for various periods of time, and phospholipase and cyclooxygenase activities were assayed as described (20) . The cells used were human foreskin fibroblasts grown from fresh explants, 3T3 C2, and L cells. No effect of IF was noted on either phospholipase or cyclooxygenase activities in these cells. DISCUSSION The data presented suggest that cellular fatty acid cyclooxygenase function may be essential for establishment of the IFmediated antiviral state in L cells. The results also indicate that the lipooxygenase products, hydroperoxy and hydroxy fatty acids, are probably not required for the establishment of IF protection. All of the nonsteroidal anti-inflammatory cyclooxygenase inhibitors tested prevented the full development of IF protection and the degree of IF reversal achieved was found to correlate with the relative potency or duration of cyclooxygenase inhibition. In contrast, none of the anti-inflammatory substances lacking cyclooxygenase inhibitory activity was found to reverse the establishment of IF antiviral protection. It thus appears reasonable to attribute to cyclooxygenase inhibition the observed reversal of the IF-associated suppression of virus replication. Addition of cyclooxygenase inhibitors after Medical Sciences: Pottathil et al.
the IF-mediated antiviral state had been established did not demonstrably alter the suppression of virus replication. Thus, it seems that the requirement for a functional cyclooxygenase enzyme is limited to some step or steps during the early development of the IF-mediated antiviral state.
The arachidonic acid metabolites synthesized by L cells did not cochromatograph with any of the products of platelet cyclooxygenase. At the concentrations of arachidonic acid incubated with the cells (3.3 ,gM, which is saturating without affecting cell viability), the radioactivity in these products represented only 0.01% of the total arachidonic acid metabolized. This relatively slow rate of arachidonic acid metabolism by the cells was consistent with the possibility that the prolonged activity of an arachidonic acid metabolite (or metabolites) may be required for establishment of the IF-mediated antiviral activity. This was also supported by data obtained by incubating L cells with the endoperoxide PGH2. This unstable intermediate in the pathway of PG biosynthesis (21) at least in principle should have bypassed the metabolic block introduced by the cyclooxygenase inhibitors. The fact that it did not suggests the possible requirement for continual biosynthesis and presence of an arachidonic acid metabolite. Incubation of PGH2 with L cells actually resulted in a partial reversal of IF protection, probably by the conversion of the endoperoxide to stable PGs, which have been shown to suppress IF protection. Because PGH2 should have supplied all of the stable PG metabolites of the cyclooxygenase pathway, the production of such prostaglandins (e.g., PGE2) from the PGH2 added could have counteracted the activity of a small quantity of a different "active" PG. Alternatively, the critical arachidonic acid metabolite required for antiviral activity might be an unstable one whose continual synthesis is required over relatively long periods of time. Endogenous PGG2 and PGH2 are possible candidates which, when added exogenously, cannot substitute for the prolonged activity required because of their short half-lives.
The reason for the observed reversal of IF action by PGE2 is not yet clear. Trofatter and Daniels (22) described inhibition of IF antiviral protection in human fibroblasts by PGEI, PGE2, and PGF2a and attributed these effects to an increase in cyclic AMP in treated-cells. Based upon the studies reported here, it seems unlikely that increased cyclic AMP is the primary cause of IF reversal because 6-keto-PGFia (which does not induce an increase in cyclic AMP) also proved to be an effective IF inhibitor. In addition, carbaprostacyclinj a stable analogue of PGI2, did not alter the IF-mediated antiviral state. it is unlikely that the addition of exogenous PGs restricted the release of endogenous arachidonic acid because the addition of exogenous arachidonic acid did not reverse the PG-mediated inhibition of IF action. Furthermore, none of the PGs tested could be shown to block cyclooxygenase function directly. It may be that the PG-associated inhibition of IF action is due to competition between the stable exogenous PGs and the putative, probably unstable intermediate for a common receptor.
Yaron et al. (5) observed an increase in endogenous PG synthesis in response to homologous IF. In contrast, in connection with the studies reported here, no qualitative or quantitative differences in PG biosynthesis were observed in L cells in response to the addition of homologous or heterologous IF.
When maximal suppression of IF activity was achieved, the replication of residual virus was seen to continue after the titers of virus had begun to decline, both in the absence of IF and also in the presence of IF when unimpeded by inhibitors (Fig. 1) . This difference in the time course of virus production probably reflects the delayed occurrence of secondary replicative cycles of residual virus in those cells still susceptible by virtue of the suppression of IF protection.
In conclusion, these studies indicate that fatty acid cyclooxygenase, which is known to catalyze the first step in PG biosynthesis, may be essential for the optimal induction of the IF-mediated antiviral state. Several exogenous, stable PGs do not substitute for the presence of a functional fatty acid cyclooxygenase in the establishment of IF antiviral protection.
